Loading clinical trials...
Loading clinical trials...
A Multicenter, First-in-Human Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma
Conditions
Interventions
Hexiris Microinvasive Scleral Trephine (MIST)
Locations
5
Canada
Eye Care Centre NB
Dieppe, New Brunswick, Canada
Miramichi EyeNB & Surgical Centres of Excellence
Miramichi, New Brunswick, Canada
Prism Eye Institute Inc.
Brampton, Ontario, Canada
Institut de l'oeil des Laurentides
Boisbriand, Quebec, Canada
Ophthalmology Clinic Bellevue
Montreal, Quebec, Canada
Start Date
January 15, 2026
Primary Completion Date
February 15, 2027
Completion Date
March 15, 2027
Last Updated
January 22, 2026
NCT07390890
NCT05902871
NCT07076303
NCT06865144
NCT05564091
NCT06223048
Lead Sponsor
Hexiris Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions